My Representative Publications!
<原著論文 & 総説>
2023 R5
  1. Mochizuki T, Ushiki T, Suzuki K, Sato M, Shiguro H, Suwabe T, Watanabe S, Edama M, Omori G, Yamamoto N, Kawase T*. Elevated IL-1β and comparable IL-1 receptor antagonist levels are characteristic features of L-PRP in female college athletes compared to male professional soccer players Int J Mol Sci 24(24):17487; 2023. (December)

  2. Nakamura M, Masuki H, Kawabata H, Watanabe T, Watanabe T, Tsujino T, Isobe K, Kitamura Y, Mourao CF, Kawase T*. Plasma Gel Made of Platelet-Poor Plasma: In Vitro Verification as a Carrier of Polyphosphate. Biomedicines 11(11):2871; 2023. (October)

  3. Uematsu T, Masuki H, Nakamura M, Kawabata H, Kitamura Y, Watanabe T, Watanabe T, Mochizuki T, Ushiki T, Kawase T*. Metformin-suppressed Platelet’s Function in vitro: Possible Relation to Delayed or Failure of Platelet-rich Fibrin Preparation. Toxicol in vitro 23:105692; 2023. (September)

  4. Mochizuki T, Ushiki, T, Suzuki K, Sato M, Ishiguro H, Suwabe T, Edama M, Omori G, Yamamoto N, Kawase T*. Characterization of Leukocyte- and Platelet-Rich Plasma Derived from Female Collage Athletes: a Cross-Sectional Cohort Study Focusing on Growth Factor, Inflammatory Cytokines, and Anti-Inflammatory Cytokine Levels. Int J Mol Sci 24(17):13592; 2023. (September)

  5. Ushiki, T, Mochizuki T, Suzuki K, Kamimura M, Ishiguro H, Suwabe T, Watanabe S, Omori G, Yamamoto N, Kawase T*. Strategic Analysis of Body Composition Indices and Resting Platelet ATP Levels in Professional Soccer Players for Better Platelet-rich Plasma Therapy. Front Bioeng Biotechnol 11:1255860; 2023. (August)

  6. Kawase T*, Suzuki K, Kamimura M, Mochizuki T, Ushiki T. Optimized protocol for preservation of human platelet samples for fluorometric polyphosphate quantification. Methods Protoc 6(4):59; 2023. (June)

  7. Mourao CF*, Lowenstein A, Mello-Machado RC, Ghanaati S, Pinto N, Kawase T, Alves GG, Messora MR. (Review) Standardization of Animal Models and Techniques for Platelet-Rich Fibrin Production: a Narrative Review and Guideline. Bioengineering 10:482; 2023. (April)

  8. Mourao CF*, Lowenstein A, Pinto N, Alves GG, Kawase T, Messora MR. (Lett to Ed) Considerations about the possible "Third Generation" of blood concentrates. J Oral Maxillofac Surg 81(3):262; 2023. (March)

(*114/157) (*6)
2022 R4
  1. Mochizuki T, Ushiki T, Watanabe S, Omori G, Kawase T*. The levels of TGFβ1, VEGF, PDGF-BB, and PF4 in platelet-rich plasma of professional soccer players: A cross-sectional pilot study. BMC J Orthop Surg Res 17: Article number:465; 2022. (October)

  2. Ushiki T, Mochizuki T, Suzuki K, Kamimura M, Ishiguro H, Suwabe T, Kawase T*. Modulation of ATP Production Influences Inorganic Polyphosphate Levels in Non-Athletes’ Platelets at the Resting State. Int J Mol Sci 23(19):11293; 2022. (September)

  3. Ushiki T, Mochizuki T, Suzuki K, Kamimura M, Ishiguro H, Watanabe S, Omori G, Yamamoto N, Kawase T*. Platelet polyphosphate and energy metabolism in professional male athletes (soccer players): A cross-sectional pilot study. Physiol Rep 10(15):e15409; 2022. (August) https://doi.org/10.14814/phy2.15409

  4. Masuki H, Uematsu T, Kawabata H, Sato A, Watanabe T, Tsujino T, Nakamura M, Okubo M, Kawase T*. Responses of promyelocytic leukemia HL60 cells as an inflammatory cell lineage model to silica microparticles used to coat blood collection tubes. Int J Implant Dent 8:24; 2022. (May) doi.org/10.1186/s40729-022-00424-4

  5. Aizawa H, Uematsu T, Sato A, Masuki H, Kawabata H, Tsujino T, Isobe K, Kitamura Y, Nagata M, Nakata K, Kawase T*. Non-destructive, spectrophotometric analysis of the thickness of the cell-multilayered periosteal sheet. Int J Implant Dent 8:21; 2022. (May) doi.org/10.1186/s40729-022-00419-1

  6. Kawase T*. (Editorial) A strategic and worldwide cooperative challenge required for the next generation of platelet concentrates. Int J Mol Sci 23(7):3437; 2022. (March)

  7. Uematsu T, Sato A, Aizawa H, Tsujino T, Watanabe T, Isobe K, Kawabata H, Kitamura Y, Tanaka T, Kawase T*. Effects of SARS-Cov-2 mRNA-vaccination on platelet polyphosphate levels and inflammation: a pilot study. Biomed Rep 16(3):21; 2022. (February) DOI: 10.3892/br.2022.1504

  8. Sato A, Kawabata H, Aizawa H, Tsujino T, Isobe K, Watanabe T, Kitamura Y, Miron RJ, Kawase T*. Distribution and quantification of activated platelets in platelet-rich fibrin matrices. Platelets 33(1):110-115; 2022. https://doi.org/10.1080/09537104.2020.1856359 (published online, December)

(*106/149) (*8)
2021 R3
  1. Shirakata Y*, Sena K, Nakamura T, Shinohara Y, Imafugi T, Setoguchi F, Noguchi K, Kawase T, Miron R. Histological evaluation of gingival and intrabony periodontal defects treated with platelet-rich fibrin using different protocols: A canine study. Oral Health and Preventive Dentistry 19:537-546; 2021. (October)

  2. Crisci A*, Kawase T, D’adamo R, Crisci M. Quantification of platelets and leukocytes in solid blood platelet concentrates for surgical use: study of an experimental technique. Chirurgia 34(4):141-53; 2021. (August)

  3. Watanabe T, Kitamura Y, Aizawa H, Masuki H, Tsujino T, Sato A, Kawabata H, Isobe K, Nakata K, Kawase T*. Fluorometric quantification of human platelet polyphosphate using 4’,6-Diamidine-2’-phenylindole dihydrochloride: application in Japanese population. Int J Mol Sci 22(14):7257; 2021. (July)

  4. Miron RJ*, Moraschini V, Fujioka-Kobayashi M, Zhang Y, Kawase T, Cosgarea R, Jepsen S, Bishara M, Canullo L, Shirakata Y, Gruber R, Calasans-Maia MD, Wang H-L, Sculean A. Use of Platelet-Rich Fibrin for the treatment of periodontal intrabony defects: A systematic review and meta-analysis. Clin Oral Invest 25(5):2461-2478.(May)

  5. Miron RJ*, Kawase T, Dham A, Zhang Y, Fujioka-Kobayashi M, Sculean A. A technical note on contamination from PRF tubes containing silica and silicone. BMC Oral Health 21, article number:135; 2021. (March)

  6. Uematsu K, Ushiki T, Ishiguro H, Ohashi R, Tamura S, Watanabe M, Fujimoto Y, Nagata M, Ajioka Y, Kawase T*. Osteoclastogenic potential of tissue-engineered periosteal sheet: effects of culture media on the ability to recruit osteoclast precursors. Int J Mol Sci 22(4):2169; 2021. (February)

  7. da Silva MT, Mourao CF, de Mello-Machado RC, de Lima Barbosa R, Sartoretto SC, Leite PEC, Javid K, Kawase T, Gomes Alves G, Calasans-Maia MD. Effects of leukocyte-platelet-rich fibrin (L-PRF) on pain, soft tissue healing, growth factors, and cytokines after third molar extraction: a randomized, split-mouth, double-blinded clinical trial. Apple Sci 11(4):1666; 2021. (February)

  8. Sato A, Aizawa H, Tsujino T, Isobe K, Watanabe T, Kitamura Y, Kawase T*. Fluorescent cytochemical detection of polyphosphates associated with human platelets. Int J Mol Sci 22(3):1040; 2021. (January)

(*98/141) (*2)
2020 R2
  1. Nakamura M, Aizawa H, Kawabata H, Sato A, Watanabe T, Isobe K, Kitamura Y, Tanaka T, Kawase T*. Platelet adhesion on commercially pure titanium plates in vitro III: effects of calcium phosphate-blasting on titanium plate biocompatibility. Int J Implant Dent 6:74;2020. (November)

  2. de Oliveira LA*, Soares RO, Buzzi M, Mourao CFAB, Kawase T, Kuckelhaus SAS. Cell and platelets composition assays by flow cytometry: basis for new platelet-rich fibrin methodologies. J Biol Regul Hemostat Agent 34(4):1379-1390; 2020. (August)

  3. Kawase T*, Mubarak S, Mourao CF. (Invited article) The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future. Bioengineering 7(3):82; 2020. (July)

  4. Miron RJ*, Moraschini V, Del Fabbro M, Piattelli A, Fujioka-Kobayashi M, Zhang Y, Saulacic N, Schaller B, Kawase T, Cosgarea R, Jepsen S, Tuttle D, Bishara M, Canullo L, Eliezer M, Stavropoulos A, Shirakata Y, Stahli A, Gruber R, Lucaciu O, Aroca S, Deppe H, Wang HL, Sculean A. Use of platelet-rich fibrin for the treatment of gingival recessions: a systematic review and meta-analysis. Clin Oral Invest 24:2543-2557; 2020. (June)

  5. Aizawa H, Tsujino T, Watanabe T, Isobe K, Kitamura Y, Sato A, Yamaguchi S, Okudera H, Kawase T*. Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors. Int J Mol Sci 21(12):4426; 2020. (June)

  6. Yamaguchi S, Aizawa H, Sato A, Tsujino T, Isobe K, Kitamura Y, Watanabe T, Okudera H, Mourao CF, Kawase T*. Concentrated growth factor matrices prepared using silica-coated plastic tubes are distinguishable from those prepared using glass tubes in platelet distribution: Application of a novel near-infrared imaging-based, quantitative technique. Front Bioeng Biotechnol (section Biometerials). 8:600; 2020. doi: 10.3389/fbioe.2020.00600 (June)

  7. Crisci A*, Kawase T, D'Adamo R, Crisci M. Use of second-generation blood products in regenerative therapy of complex extremity wounds. Medicina e Chirurgia della Caviglia e del Piede 44(1):3-13; 2020. (April)

  8. Aizawa H, Kawabata H, Sato A, Masuki H, Watanabe T, Tsujino T, Isobe K, Nakamura M, Nakata K, Kawase T*. A comparative study of the effects of anticoagulants on pure platelet-rich plasma quality and potency. Biomedicines 8(3):42; 2020. (February)

  9. Masuki H, Isobe K, Kawabata H, Tsujino T, Yamaguchi S, Watanabe T, Sato A, Aizawa H, Mourao CF, Kawase T*. Acute cytotoxic effects of silica microparticles used for coating of plastic blood-collection tubes on human periosteal cells. Odontology 108:545-552; 2020. (August)
    https://doi.org/10.1007/s10266-020-00486-z. (published online, 2020 January)

(*95/133) (*6)
2019 H31
  1. Crisci A*, Kawase T, D’Adamo R, Crisci M. Experimental research on a technique for quantification of platelets and leukocytes in second-generation platelet concentrates. Int J Curr Med Pharm Res 5 (12):4792-1799; 2019. (December)

  2. Crisci A*, Kawase T, D’Adamo R, Crisci M, Crisci F. The Usefulness of Second Generation Platelet Concentrates in Regenerative Therapy of Limbs’ Complex Wounds. Adv Res Foot Ankle 2: 116; 2019. DOI: 10.29011/ 2688-6413.100016 (December)

  3. Tsujino T, Takahashi A, Isobe, K, Kitamura Y, Okuda K, Nakata K, Kawase T*. Platelet adhesion on commercially pure titanium plates in vitro II. Immunofluorescence visualization of PDGF-B, TGFβ1, and PPARγ released from activated, adherent platelets. Dent J 7(4):109; 2019. (November)

  4. Takahashi A, Tsujino T, Yamaguchi S, Isobe K, Watanabe T, Kitamura Y, Okuda K, Nakata K, Kawase T*. Distribution of platelets, TGFβ1, PDGF-BB, VEGF, MMP9 and fibronectin in advanced platelet-rich fibrin (A-PRF) and concentrated growth factors (CGF) matrices. J Invest Clin Dent 10:e12458; 2019. (November)

  5. Tsujino T, Masuki H, Nakamura M, Isobe K, Kawabata H, Aizawa H, Watanabe T, Kitamura Y, Okudera H, Okuda K, Nakata K, Kawase T*. Striking differences in platelet distribution between advanced-platelet-rich fibrin and concentrated growth factors: effects of silica-containing plastic tubes. J Funct Biomater 10(3):43; 2019. (September)

  6. Tsujino T, Takahashi A, Yamaguchi S, Watanabe T, Isobe K, Kitamura Y, Tanaka T, Nakata K, Kawase T*. Evidence for contamination of silica microparticles in advanced platelet-rich fibrin matrix prepared using silica-coated plastic tubes. Biomedicines 7(2):45; 2019. (June)

  7. Tsujino T, Isobe K, Kawabata H, Aizawa H, Yamaguchi S, Kitamura Y, Masuki H, Watanabe T, Okudera H, Nakata K, Kawase T*. Spectrophotometric determination of the aggregation activity of platelets in platelet-rich plasma for better quality control. Dent J 7(2):61; 2019. (June)

  8. Tsukioka T, Hiratsuka T, Nakamura M, Watanabe T, Kitamura Y, Isobe K, Okudera T, Okudera H, Azuma A, Uematsu K, Nakata K, Kawase T*. An on-site preparable, novel bone-grafting complex consisting of human platelet-rich fibrin and porous particles made of a recombinant collagen-like protein. J Biomed Mater Res B 107B(5):1420-1430; 2019.(June)

  9. Kawase T*, Takahashi A, Watanabe T, Tsujino T. (Invited article) Proposal for point-of-care testing of PRP quality. Int J Growth Factors Stem Cells Dent 2(1):13-17; 2019. (April)

  10. Kawase T*, Nagata M, Okuda K, Ushiki T, Fujimoto Y, Watanabe M, Ito A, Nakata K. Platelet-rich fibrin extract: a promising fetal bovine serum alternative in explant cultures of human periosteal sheets for regenerative therapy. Int J Mol Sci 20(5):1053; 2019. (February)

  11. Takahashi A, Takahashi S, Tsujino T, Isobe K, Watanabe T, Kitamura Y, Watanabe Tk, Nakata K, Kawase T*. Platelet adhesion on commercially pure titanium plates in vitro I. Effects of plasma components and involvement of the von Willebrand factor and fibronectin. Int J Implant Dent 5:5; 2019. (Feburary)

  12. Tsuchimochi M*, Yamaguchi H, Hayama K, Okada Y, Kawase T, Suzuki T, Tsubokawa N, Wada N, Ochiai A, Fujii S, Fujii H. Imaging of metastatic cancer cells in sentinel lymph nodes using affibody probes and a potential theranostic approach in vivo. Int J Mol Sci 20(2):427; 2019. (January)

(*89/124) (*9)
2018 H30
  1. Kitamura Y, Suzuki M, Tsukioka T, Isobe K, Tsujino T, Watanabe T, Watanabe T, Okudera H, Nakata K, Tanaka T, Kawase T*. Spectrophotometric determination of platelet counts in platelet-rich plasma. Int J Implant Dent 4:29; 2018. (October)

  2. Toyoda H, Isobe K, Tsujino T, Koyata Y, Ohyagi F, Watanabe T, Nakamura M, Kitamura Y, Okudera H, Nakata K, Kawase T*. Direct activation of platelets by addition of CaCl2 leads coagulation of platelet-rich plasma. Int J Implant Dent 4:23; 2018. (August)

  3. Kitamura Y, Isobe K, Kawabata H, Tsujino T, Watanabe T, Nakamura M, Toyoda T, Okudera H, Okuda K, Nakata K, Kawase T*. Quantitative evaluation of morphological changes in activated platelets in vitro using digital holographic microscopy. Micron 113:1-9; 2018. (June)

  4. Kawase T*, Okuda K. (Review) Comprehensive quality control of the regenerative therapy using platelet concentrates: The current situation and prospects in Japan. BioMed Res Int Volume 2018, Article ID 6389157, 10 pages. (May)

  5. Yamaguchi H, Hayama K, Sasagawa I, Okada Y, Kawase T, Tsubokawa N, Tsuchimochi M*. HER2-targeted multifunctional silica nanoparticles specifically enhance the radiosensitivity of HER2-overexpressing breast cancer cells. Int J Molec Sci 19:908; 2018. doi:10.3390/ijms19030908 (March)

  6. Kitamura Y, Watanabe T, Nakamura M, Isobe K, Kawabata H, Uematsu K, Okuda K, Nakata K, Tanaka T, Kawase T*. Platelet counts in insoluble platelet-rich fibrin clots: a direct method for accurate determination. Front Bioeng Biotechnol (section Tissue Engineering and Regenerative Medicine) 6:4; 2018. doi: 10.3389/fbioe.2018.00004 (February)

(*80/112) (*5)
2017 H29
  1. Kawase T*, Tanaka T. (Commentary) An updated proposal for terminology and classification of platelet-rich fibrin. Regen Ther 7:80-81; 2017. (November)

  2. Kawabata H, Isobe K, Watanabe T, Okudera T, Nakamura M, Suzuki M, Ryu J, Kitamura Y, Okudera H, Okuda K, Nakata K, Kawase T*. Quality assessment of platelet-rich fibrin-like matrix prepared from extendedly stored whole blood samples. Biomedicines 5:57; 2017. (September)

  3. 川瀬知之*, 渡辺泰典, 奥田一博. (ミニ総説) 多血小板血漿とそこから派生した血小板濃縮材料: 再生医療に関与する歯科医が押さえて おきたいポイント. 日本歯周病学会誌 59(2):68-76, 2017. (August)

  4. Horimizu M, Kubota T*, Kawase T, Nagata M, Kobayashi M, Okuda K, Nakata K, Yoshie H. Synergistic effects of the combined use of human cultured periosteal sheets and platelet-rich fibrin on bone regeneration: an animal study. Clin Exp Dent Res 3(4):134-141, DOI: 10.1002/cre2.71; 2017. (August)

  5. Isobe M, Watanabe T, Kawabata H, Kitamura Y, Okudera T, Okudera H, Uematsu K, Okuda K, Nakata K, Tanaka T, Kawase T*. Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF) and platelet-poor plasma-derived fibrin (PPTF). Int J Implant Dent 3:17; 2017. (May)

  6. Isobe M, Suzuki M, Watanabe T, Kitamura Y, Suzuki T, Kawabata H, Nakamura M, Okudera T, Okudera H, Uematsu K, Nakata K, Tanaka T, Kawase T*. Platelet-rich fibrin prepared from stored whole-blood samples. Int J Implant Dent 3:6; 2017. (March)

  7. Watanabe T, Isobe K, Suzuki T, Kawabata H, Nakamura M, Tsukioka T, Okudera T, Okudera H, Uematsu K, Okuda K, Nakata K, Kawase T*. An evaluation of the accuracy of the subtraction method used for determining platelet counts in advanced platelet-rich fibrin and concentrated growth factor preparations. Dent J 5(7):doi:10.3390/dj5010007; 2017. (January)

(75/106) (*6)
2016 H28

  1. Minbu H, Kawase T, Ochiai A, Taniguchi M, Tanaka T*. (膜誌論文賞受賞論文) Preparation of a poly(L-lactic acid) Membrane scaffold with open finger-Like pores prepared by a nonsolvent-induced phase separation method with the aid of a surfactant. Membrane (膜学会誌) 41(6):304-310. (December)

  2. Masuki H, Okudera T, Watanabe T, Suzuki M, Nishiyama K, Okudera H, Nakata K, Uematsu K, Su CY, Kawase T*. Growth factor and pro-inflammatory cytokine contents in PRP, plasma rich in growth factors (PRGF), advanced-platelet-rich fibrin (A-PRF) and concentrated growth factors (CGF). Int J Implant Dent 2:19; 2016. (August)

  3. Kawase T*, Okuda K, Nagata M, Tsuchimochi M, Yoshie H, Nakata K. Non-invasive, quantitative assessment of the morphology of γ-irradiated human mesenchymal stem cells and periosteal cells using digital holographic microscopy. Int J Radiat Biol 92(12):796-805; 2016. (December)

  4. Ogawa S, Hoshina H, Nakata K, Yamada K, Uematsu K, Kawase T, Takagi R, Nagata M*. High resolution three-dimensional computed tomography analysis of the clinical efficacy of cultured autogenous periosteal cells in sinus lift bone grafting. Clin Implant Dent Relat Res 18(4):707-716; 2016. (July)

  5. Yamaguchi H, Tsuchimochi M*, Hayama K, Kawase T, Tsubokawa N. Dual-labeled near-infrared/99mTc imaging probes using PAMAM-coated silica nanoparticles for the imaging of HER2-expressing cancer cells. Int J Mol Sci doi:10.3390/ijms17071086. (July)

  6. Nishiyama K, Okudera T, Watanabe T, Isobe K, Suzuki M, Masuki H, Okudera H, Uematsu K, Nakata K, Kawase T*. Basic characteristics of plasma rich in growth factors (PRGF): blood cell components and biological effects. Clin Exp Dent Res 2(2):96-103, DOI: 10.1002/cre2.26, 2016. (March)

  7. Kawase T*, Hayama K, Tsuchimochi M, Nagata M, Okuda K, Yoshie H, Burns DM, Nakata K. Evaluating the safety of somatic periosteal cells by flow-cytometric analysis monitoring the history of DNA damage. Biporeserv Baiobank 14(2):129-137; 2016. (April)

(71/99) (*4)
2015 H27

  1. Kobayashi M, Kawase T*, Okuda K, Wolff LF, Yoshie H. In vitro immunological and biological evaluations of the angiogenic potential of platelet-rich fibrin preparations: a standardized comparison with PRP preparations. Int J Implant Dent 1(1):31; 2015. (November)

  2. Okuda K*, Nakajima Y, Kawase T, Kobayashi M, Kamiya M, Wolff LF, Yoshie H. Platelet-rich fibrin membrane combined with beta-tricalcium phosphate for treatment of infrabony defects in chronic periodontitis: a case series. Jacobs J Dent Res 2(3):022; 2015.

  3. Kamiya M, Kawase T*, Hayama K, Tsuchimochi M, Okuda K, Yoshie H. X-ray-induced damages to the submandibular salivary glands in mice: an analysis of strain-specific responses. BioRes Open Access 4.1:307-318; 2015. (June)

  4. Kawase T*, Tanaka T, Okuda K, Tsuchimochi M, Oda M, Hara T. Quantitative single-cell motility analysis of platelet-rich plasma-treated endothelial cells in vitro. Cytoskeleton 72(5):246-255; 2015. (July)

  5. Kawase T*. (Invited review) Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: Basic principles and concepts underlying recent advances. Odontology 103:126-135; 2015. (June)

  6. Minbu H, Ochiaki A, Kawase T, Taniguchi M, LLoyd DR, Tanaka T*. Preparation of poly(L-lactic acid) microfiltration membranes by nonsolvent-induced phase separation method with the aid of surfactants. J Membr Sci 479:85-94; 2015.

  7. 川瀬知之*. (依頼総説) PRF膜の歯周再生治療への応用. 膜 (日本膜学会誌) 40(3):118-123; 2015.

  8. Kawase T*, Kamiya M, Hayama K, Nagata M, Okuda K, Yoshie H, Burns DM, Tsuchimochi M, Nakata K. X-ray and UVC irradiation-induced γ-H2AX and p53 formation in normal human periosteal cells in vitro: Markers for quality control in cell therapy. Cytotherapy 17(1):112-23; 2015.

  9. Kawase T*, Kamiya M, Kobayashi M, Tanaka T, Okuda K, Wolff LF, Yoshie H. The heat-compression technique for the conversion of platelet-rich fibrin preparation to a barrier membrane with a reduced rate of biodegradation. J Biomed Mater Res B 103B:825-831; 2015.

(92) (*7)
2014 H26

  1. Kawase T*, Uematsu K, Kamiya M, Nagata M, Okuda K, Burns DM, Nakata K, Yoshie H. Real-time quantitative PCR and flow-cytometric analyses of cell adhesion molecules expressed in human cell-multilayered periosteal sheets in vitro. Cytotherapy 16:653-661; 2014.

  2. Kawase T*, Tanaka T, Minbu H, Kamiya M, Oda M, Hara T. An atmospheric-pressure plasma-treated titanium surface potentially supports initial cell adhesion, growth and differentiation of cultured human prenatal-derived osteoblastic cells. J Biomed Mater Res B 102(6):1289-1296; 2014.

(83) (*2)
2013 H25

  1. Uematsu K, Nagata M*, Kawase T, Suzuki K, Takagi R. Application of stem cell media to explant culture of human periosteum: an optimal approach for preparing osteogenic cell material. J Tissue Eng 4:2041731413509646; 2013.

  2. Nagata M*, Noman AA, Suzuki K, Kurita H, Ohnishi M, Ohyama T, Kitamura N, Kobayashi T, Uematsu K, Takahashi K, Kodama N, Kawase T, Hoshina H, Ikeda N, Shingaki S, Takagi R. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma. BMC Cancer 13:410; 2013.

  3. Kawase T*, Uematsu K, Nagata M, Okuda K, Burns DM, Yoshie H. (Proceeding) Biological and biomechanical characterization of highly self-multilayered human periosteal sheets as an osteogenic grafting material. Cytotherapy 15(4) (supplement):S45-46; 2013 (April)

  4. Horimizu M, Kawase T*, Tanaka T, Okuda K, Nagata M, Burns DM, Yoshie H. Biomechanical evaluation by AFM of cultured human cell-multilayered periosteal sheets. Micron 48:1-10; 2013. (April)

  5. Horimizu M, Kawase T*, Nakajima Y, Okuda K, Nagata M, Wolff LF, Yoshie H. An improved freeze-dried PRP-coated biodegradable material suitable for connective tissue regenerative therapy. Cryobiol 66(3):223-232; 2013. (June)

  6. Kouya T, Tada S, Minbu H, Nakajima Y, Horimizu M, Kawase T, Lloyd DR, Tanaka T*. Microporous membranes of PLLA/PCL blends for periosteal tissue scaffold. Mater Lett 95:103-106; 2013.

  7. Okuda K*, Kawase T, Nagata M, Yamamiya K, Nakata K, Wolff, LF, Yoshie H. Tissue engineered cultured periosteum sheet application to treat infrabony defects: case series and 5-year results. Int J Periodont Rest Dent 33(3):281-287; 2013. (April)

  8. Uematsu K, Kawase T*, Nagata M, Suzuki K, Okuda K, Yoshie H, Burns DM, Takagi R. Tissue culture of human alveolar periosteal sheets using a stem-cell culture medium (MesenPRO-RSTM): In vitro expansion of CD146-positive cells and concomitant upregulation of osteogenic potential in vivo. Stem Cell Res 10(1):1-19; 2013.

(81) (*4)
2012 H24

  1. Kobayashi M, Kawase T*, Horimizu M, Okuda K, Wolff LF, Yoshie H. A proposed protocol for the standardized preparation of PRF membranes for clinical use. Biologicals 40:323-329; 2012.

  2. Kawase T*, Tanaka T, Nishimoto T, Okuda K, Nagata M, Burns DM, Yoshie H. An osteogenic grafting complex composed of human periosteal sheet and a porous poly(L-lactic acid) membrane scaffold: Biocompatibility, biodegradability, and cell fate in vivo. J Bioact Compat Polym 27(2):107-121; 2012.

  3. Nakajima Y, Kawase T*, Okuda K, Wolff LF, Yoshie H. Bioactivity of freeze-dried platelet-rich plasma in an adsorbed form on a biodegradable polymer material. Platelets 23(8):594-603; 2012.

  4. Yamaguchi H, Suzuki K, Nagata M, Kawase T, Sukumaran V, KawauchiY, Yokoyama J, Tomita M, Kawachi H, Watanabe K, Yoneyama H, Asakura H, Takagi R. Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium. Med Mol Morphol 45(3):140-151; 2012.

  5. Nagata M*, Hoshina H, Li M, Arasawa M, Uematsu K, Ogawa S, Yamada K, Kawase T, Suzuki K, Ogose A, Fuse I, Okuda K, Uoshima K, Nakata K, Yoshie H, Takagi R. A clinical study of alveolar bone tissue engineering with cultured autogenous periosteal cells: coordinated activation of bone formation and resorption. Bone 50(5):1123-1129; 2012.

  6. Kamiya M, Kawase T*, Kobayashi M, Sekine Y, Okuda K, Nagata M, Fuse I, Nakata K, Wolff LF, Yoshie H. A short-term preservation of human cultured periosteal sheets, osteogenic grafting materials, using a commercial preservation solution containing epigallocatechin-3-gallate (Theliokeep(R)) under chilled conditions. Biopreserv Biobank 10(3):245-252; 2012.

  7. 奥田一博*、川瀬知之、中田 光、吉江弘正. (依頼総説) 培養骨膜シート移植を応用した歯周組織再生法. 再生医療 (日本再生医療学会雑誌) 11(1):51-56; 2012.

  8. 川瀬知之*、奥田一博、吉江弘正. (依頼総説) 歯周病の再生治療材料;ヒト自家骨膜シートの特性. 顕微鏡 (日本顕微鏡学会和文誌) 47(4):216-222; 2012.

(73) (*5)
2011 H23

  1. Nakayama H, Kawase T*, Okuda K, Wolff LF, Yoshie H. In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: Dual-channel quantitative evaluation of volume and mineralization. Acta Radiol 52(9):978-988; 2011. (including figures printed in the front page)

  2. Kawase T*, Kogami H, Nagata M, Uematsu K, Okuda K, Burns DM, Yoshie H. Manual cryopreservation of human alveolar periosteal tissue segments: Effects of pre-culture on recovery rate. Cryobiol 62(3):202-209; 2011.

  3. Suzuki K, Sun X, Nagata M, Kawase T, Yamaguchi H, Sukumaran V, KawauchiY, Kawachi H, Nishimoto T, Watanabe K, Yoneyama H, Asakura H. Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathol Int 61(4):228-238; 2011.

  4. Nakayama H, Burns DM, Kawase T*. Nondestructive microstructural analysis of porous bioceramics by microfocus X-ray computed tomography (micro-CT): A proposed protocol for standardized evaluation of porosity and interconnectivity between macro-pores. J Nondest Eval 30(2):71-80; 2011.

  5. Nagata M, Nuckolls GH, Wang X, Seki Y, Kawase T, Suzuki K, Noman A, Takahashi K, Nonaka K, Takahashi I, Shum L, Slavkin HC. The primary site of the acrocephalic feature in Apert syndrome is a dwarf cranial base with accelerated chondrocytic differentiation due to aberrant activation of the FGFR2 signaling. Bone 48(4):847-856; 2011.

  6. Kawase T*, Tanaka T, Nishimoto T, Okuda K, Nagata M, Burns DM, Yoshie H. Improved adhesion of human cultured periosteal sheets to a porous poly(L-lactic acid) membrane scaffold without the aid of exogenous adhesion biomolecules. J Biomed Mater Res A 98(7):100-113; 2011.
(65) (*4)
2010 H22

  1. (育成) Kawase T*, Yamanaka K, Suda Y, Kaneko T, Okuda K, Kogami H, Nakayama H, Nagata M, Wolff LF, Yoshie H. Collagen-coated poly(L-lactide-co-ε-caprolactone) film: A promising scaffold for cultured periosteal sheets. J Periodontol 81(11):1653-1662; 2010.

  2. 川瀬知之*. (依頼総説) (日本歯周病学会学術賞受賞論文) 歯周組織再生を促す生理活性物質と細胞療法に関するトランスレーショナルリサーチ. 日本歯周病学会誌 52(1):3-11; 2010.

  3. (育成) Kawase T*, Okuda K, Kogami H, Nakayama H, Nagata M, Sato T, Wolff LF, Yoshie H. Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: An animal implantation study using nude mice. J Periodontol 81(3):420-427; 2010.

  4. (育成) Kawase T*, Okuda K, Kogami H, Nakayama H, Nagata M, Yoshie H. Osteogenic activity of human periosteal sheets cultured on salmon collagen-coated ePTFE meshes. J Mater Sci Mater Med 21(2):731-739; 2010.

  5. (育成) Nakayama H, Kawase T*, Okuda K, Kogami H, Inoue H, Oda T, Hayama K, Tsuchimochi M, Wolff LW. Evaluation by bone scintigraphy of osteogenic activity of commercial bioceramics (porous beta-TCP and HAp particles) subcutaneously implanted in rats. J Biomater Appl 24(8):751-768; 2010.
(59) (*5)
2009 H21

  1. (育成) Okuda K*, Yamamiya K, Kawase T, Mizuno H, Ueda M, Yoshie H. Treatment of human infrabony periodontal defects by grafting human cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite granules: case series. J Int Acad Periodontol 11(3):206-213; 2009.

  2. (育成) Kawase T*, Okuda K, Kogami H, Nakayama H, Nagata M, Nakata K, Yoshie H. Characterization of human cultured periosteal sheets expressing bone-forming potential: in vitro and in vivo animal studies. J Tissue Eng Reg Med 3:218-229; 2009.

  3. 吉江弘正*、奥田一博、川瀬知之. (依頼総説) 歯肉細胞シート・骨膜シートを用いた歯周再生治療. 日本口腔外科学会雑誌 55(9):432-439;2009.

  4. (育成) 中山 均、川瀬知之*. (テクニカルノート) X線マイクロCTによる生体活性セラミックス 多孔体の微小構造解析. 歯科放射線 49(3):33-40;2009.
(54) (*2)
2008 H20

  1. (育成) Yamamiya K, Okuda K*, Kawase T, Wolff LF, Yoshie H. Tissue-engineered cultured periosteum used with platelet-rich plasma and hydroxyapatite in treating human osseous defects. J Periodontol 79:811-818; 2008.
(50) (*0)
2007 H19

  1. Kawase T*, Okuda K, Yoshie H. Extracellular ATP and ATPgS suppress the proliferation of human periodontal ligament cells by different mechanisms. J Periodontol 78(4):748-756; 2007.
(49) (*1)
2006

  1. Kawase T*, Okuda K, Yoshie H. A hepatocyte growth factor (HGF)/receptor autocrine loop regulates constitutive self-renewal of human periodontal ligament cells but reduces sensitivity to exogenous HGF. J Periodontol 77(10):1723-1730; 2006.
(48) (*1)
2005

  1. Kawase T*, Okuda K, Saito, Y, Amizuka N, Suzuki H, Yoshie H. Platelet-rich plasma (PRP) provides nucleus for mineralization in cultures of partially differentiated periodontal ligament cells. In Vitro Cell Dev Biol-Animal 41(5):171-176; 2005.

  2. Kawase T*, Okuda K, Burns DM. Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)2,7]-CGRP and CGRP8-37. Am J Physiol (Cell Physiol) 289(4):C811-818;2005.

  3. Kawase T*, Okuda K, Saito Y, Yoshie H. In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-beta or platelet-derived growth factor. J Periodontol 76(5):760-767; 2005.

  4. Okuda K*, Tai H, Tanabe K, Suzuki H, Sato T, Kawase T, Saito Y, Wolff LF, Yoshie H. Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: A comparative controlled clinical study. J Periodontol 76(6):890-898; 2005.

  5. 原田美樹子,土持 眞*,川瀬知之. 扁平上皮癌細胞とヒト歯肉由来不死化ケラチノサイトの分化、増殖に及ぼす副甲状腺 ホルモン関連蛋白(PTHrP)の影響. 日本口腔科学会雑誌 54(1):12-21;2005.
(47) (*3)
2004

  1. Burns DM*, Stehno-Bittle L, Kawase T. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol (Cell Physiol) 287(2):C457-467: 2004.

  2. Kawase T*, Oguro A. Granulocyte-colony-stimulating factor synergistically augments 1,25-dihydroxyvitamin D3-induced monocytic differentiation in murine bone marrow cell cultures. Horm Metab Res 36(7):445-452: 2004.

(42) (*1)
2003

  1. Oguro A, Kawase T*, Orikasa M. NaF induces early differentiation of murine bone marrow cells along the granulocytic pathway, but not the monocytic or pre-osteoblastic pathway, in vitro. In Vitro Cell Dev Biol-Animal 39(5):243-248: 2003.

  2. Kawase T*, Okuda K, Burns DM. Immature human osteoblastic MG63 cells predominantly express a subtype 1-like calcitonin gene-related peptide receptor that inactivates extracellular signal response kinase by a cAMP-dependent mechanism. Eur J Pharmacol 470(3):125-137: 2003. ERRATUM: EJP 485:345.

  3. Kawase T*, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 74(6):858-864: 2003.

  4. Okuda K*, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74(6):849-857: 2003.

(40) (*3)
2002

  1. Kawase T*, Okuda K, Yoshie H, Burns DM. Anti-TGF-beta antibody blocks enamel matrix derivative-induced up-regulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodont Res 37(4):255-262: 2002.

(36) (*1)
2001

  1. Kawase T*, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodont Res 36(6):367-376: 2001.

(35) (*1)
2000

  1. Matsumoto S*, Takahashi T, Ikeda M, Nishikawa T, Yoshida S, Kawase T. Effects of NG-monomethyl-L-arginine on Ca2+ current and nitric-oxide synthase in rat venticular myocytes. J Pharmacol Exp Ther 294(1):216-223: 2000.

  2. Kawase T*, Okuda K, Yoshie H, Burns DM. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodont Res 35(5):291-300: 2000.

(34) (*1)
1999

  1. Kawase T*, Orikasa M, Oguro A, Burns DM. Possible regulation of epidermal growth factor receptor tyrosine autophosphorylation by calcium and G-proteins in chemically permeabilized UMR106 cells. Arch Oral Biol 44(2):157-171: 1999.

  2. Kawase T*, Okuda K, Wu H-C, Yoshie H, Hara K, Burns DM. Calcitonin gene-related peptide acts as a mitogen for human Gin-1 gingival fibroblasts by activating the MAP kinase signalling pathway. J Periodont Res 34(3):160-168: 1999.

(32) (*2)
1998

  1. Kawase T*, Orikasa M, Oguro A, Burns DM (1998) Up-regulation of inducible nitric oxide (NO) synthase and NO production in HL-60 cells stimulated to differentiate by phorbol 12-myristate 13-acetate plus 1,25-dihydroxyvitamin D3 is not obtained with dimethyl sulfoxide plus 1,25-dihydroxyvitamin D3. Calcif Tissue Int 63(1):27-35.

  2. Kawase T*, Burns DM (1998) Calcitonin gene-related peptide stimulates potassium efflux through ATP-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells. Endocrinology 138(8):3492-3502.

(30) (*2)
1996

  1. Kawase T, Howard GA, Roos BA, Burns DM* (1996) Calcitonin gene-related peptide rapidly inhibits calcium uptake in osteoblastic cell lines via activation of ATP-sensitive potassium channels. Endocrinology 137(3):984-990.

  2. Kawase T*, Oguro A, Orikasa M, Burns DM (1996) Characteristics of NaF-induced differentiation of HL-60 cells. J Bone Miner Res 11(11):1676-1687.

(28) (*1)
1995

  1. Ogata S, Suzuki A, Kawase T* (1995) A rapid quantitative analysis of intracellular nucleotides in osteoblasts using high-performance liquid chromatography. Jpn J Oral Biol 37:1-8.

  2. Kawase T, Howard GA, Roos BA, Burns DM* (1995) Diverse actions of calcitonin gene-related peptide on intracellular free Ca2+ concentrations in UMR 106 osteoblastic cells. Bone 16 (Supple 1)(4):379s-384s.

  3. Kawase T*, Orikasa M, Ogata S, Burns DM (1995) Protein tyrosine phosphorglation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line. Arch Oral Biol 40(10):921-930.

  4. Kawase T*, Ogata S, Orikasa M, Burns DM (1995) 1,25-Dihydroxyvitamin D3 promotes prostaglandin E1-induced differentiation of HL-60 cells. Calcif Tissue Int 57(5):359-366.

(26) (*3)
1993

  1. Kawase T*, Orikasa M, Suzuki A (1993) Effect of bradykinin on intracellular signaling systems in a rat clonal dental pulp cell line. Arch Oral Biol 38(1):43-48.

  2. Orikasa M*, Kawase T, Suzuki A (1993) Induction of macrophagic and granulocytic differentiation of murine bone marrow progenitor cells by 1, 25-dihydroxyvitamin D3. Calcif Tissue Int 53(3):193-200.

(22) (*1)
1992

  1. Kawase T*, Orikasa M, Suzuki A (1992) Effect of phorbol myristate on release of arachidonic acid and its metabolites in the osteoblastic MOB 3-4 cell line and its subclone, MOB 3-4-F2. Cell Signal 4(1):51-59.

  2. Kawase T, van Breeman C* (1992) Aluminum fluoride induces a reversible Ca2+ sensitization in (Alpha)-toxin-permeabilized vascular smooth muscle. Eur J Pharmacol 214:39-44.

  3. Nishimura J, Moreland S, Ahn HY, Kawase T, Moreland RS, van Breemen C* (1992) Endothelin increases myofilament Ca2+ sensitivity in (Alpha)-toxin-permeabilized rabbit artery. Circ Res 71:951-959.

  4. Kawase T*, Orikasa M, Suzuki A (1992) Phorbol ester-like action of staurosporine on the cAMP response to prostaglandin E2 in two macrophage-like cell lines at distinct differentiation stages. Cell Signal 4(5):479-485.

(20) (*2)
1991

  1. Kawase T*, Orikasa M, Suzuki A (1991) Effects of prostaglandin E2 and F2(Alpha) on cytoplasmic pH in a clonal osteoblast-like cell line, MOB3-4. J Cell Physiol 146(1):141-147.

  2. Orikasa M*, Kawase T, Shimizu F, Suzuki A (1991) Establishment of murine macrophage-like mutant and hybrid cell line: comparative analysis of the differentiation induced by 1(Alpha), 25-dihydroxyvitamin D3 and recombinant murine interferon(Gamma). Cell Immunol 132(2):350-365.

  3. Kawase T*, Orikasa M, Suzuki A (1991) Phorbol ester (TPA) reduces prostaglandin E2-stimulated cAMP production by desensitization of prostaglandin E2 receptors in a clonal osteoblast-like cell line, MOB 3-4. Calcif Tissue Int 48:167-175.

  4. Kawase T*, Orikasa M, Suzuki A (1991) Starvation of a clonal osteoblast-like cell line, MOB 3-4-F2, down-regulates prostaglandin E2 receptors but increases cAMP response to prostaglandin E2. Cell Signal 3(2):153-158.

  5. Kawase T*, Orikasa M, Suzuki A (1991) Aluminumfluoride and epidermal growth factor-stimulated DNA synthesis in MOB 3-4-F2 cells. Pharmacol Toxicol 69(5):330-337.

  6. 折笠紀晶、草刈玄*、川瀬知之、鈴木章俊 (1991) 低出力レーザーの骨に対する影響--病理組織学的および細胞性理学的検討--  補綴学会誌 35:339-350.

(16) (*4)
1990

  1. Kawase T*, Suzuki A. Initial responses of a clonal osteoblast- like cell line, MOB 3-4, to phosphatidic acid in vitro. Bone Miner 10(1):61-70; 1990.

  2. Kawase T*, Orikasa M, Suzuki A. A clonal prostaglandin-responsive cell line (RDP4-1) derived from rat dental pulp. Bone Miner 11(2):163-175; 1990.

(10) (*2)
1989

  1. Kawase T*, Suzuki A. Studies on the transmembrane migration of fluoride and its effects on proliferation of L-929 fibroblasts(L cells) in vitro. Arch Oral Biol 34(2):103-107; 1989.

  2. Kawase T*, Suzuki A. Fluoride-induced cytoplasmic acidification: possible role of protein kinase C in BCECF-loaded L929 cells. Pharmacol Toxicol 64(5):426-428; 1989.

  3. Kawase T*, Ishikawa I, Orikasa M, Suzuki A. Aluminium enhances the stimulato*ry effect of NaF on prostaglandin E2 synthesis in a clonal osteoblast-like cell line, MOB 3-4, in vitro. J Biochem 106(1):8-10; 1989.

(8) (*3)
1988
  1. Kawase T*, Suzuki A. Phosphatidic acid induced Ca2+ mobilization in osteoblasts. J Biochem 103(4):581-582; 1988.

  2. Kawase T*, Ishikawa I, Suzuki A. NaF-induced Ca2+ mobilization is dependent upon the culture density in a parathyroid hormone-responsive osteoblast-like cell line. Life Sci 43(26):2241-2247; 1988.

(5) (*2)
1987

  1. Kawase T*, Ishikawa I, Suzuki A. The calcium-mobilizing action of low concentrations of sodium fluoride in single fibroblasts. Life Sci 42(12):1253-1257; 1987.

  2. 川瀬知之*、石川市次郎、鈴木章俊. マウス新生仔頭蓋骨より分離・培養した造骨細胞の石灰化能に関する研究. 新潟歯学会誌 17:1-6; 2987.

(3) (*2)
1986

  1. 小黒章*、川瀬知之、堀井欣一. ネパール王国カトマンズ市及び近郊バランブー村における歯科検診--歯周と歯列の状態について--. 新潟歯学会誌 16:21-26; 1986.

(1) (*0) inserted by FC2 system